Skip to main content
. 2021 Jun 29;34(4):1105–1140. doi: 10.1007/s00148-021-00856-z

Table 4.

Full sample: Sensitivity overview

Dependent variable
Cases log Cases R0 log R0
(1) (2) (3) (4)
Original estimates − 2.252∗∗∗ − 0.358∗∗ − 0.279∗∗∗ − 0.314∗∗∗
(0.632) (0.144) (0.100) (0.112)
w/o Bratislava district − 2.376∗∗∗ − 0.423∗∗∗ − 0.214∗∗ − 0.265∗∗
(0.683) (0.154) (0.106) (0.118)
w/o Košice district − 2.279∗∗∗ − 0.365∗∗ − 0.271∗∗∗ − 0.301∗∗∗
(0.652) (0.148) (0.103) (0.115)
w/o Bratislava and Košice districts − 2.428∗∗∗ − 0.442∗∗∗ − 0.195 − 0.301∗∗∗
(0.713) (0.160) (0.111) (0.115)
Unweighted − 1.790∗∗ − 0.312 − 0.133 − 0.194
(0.694) (0.173) (0.125) (0.138)
PCR only − 1.654∗∗∗ − 0.249 − 0.247∗∗∗ − 0.266∗∗
(0.450) (0.138) (0.093) (0.111)
Considering mobility − 2.537∗∗∗ − 0.415∗∗∗ − 0.310∗∗∗ − 0.329∗∗∗
(0.719) (0.154) (0.108) (0.121)
R0 based on 7 day avg − 0.213∗∗∗ − 0.216∗∗∗
(0.078) (0.078)
7 day avg of R0 − 0.204∗∗ − 0.196∗∗
(0.085) (0.079)
Date of Second Mass Testing (Nov 1) − 0.749 0.120 − 0.041 − 0.101
(0.703) (0.142) (0.144) (0.115)

This table presents the results for the key parameter β1 from Eq. (1) estimated on a full sample with population sizes used as weights. Rows 2 to 5 show the results when excluding large urban districts from our analysis and using unweighted regressions respectively (Appendix A2.1). Row 6 presents the results considering only test results from PCR data only (Appendix A2.2) and row 7 shows the results when including workplace mobility in the estimation (Appendix A2.3). Rows 8 and 9 present results based on R0 measure calculated on a 7-day average of infection cases and on a 7-day average of R0 respectively (Appendix A2.4). Finally, the last row shows estimates from placebo regression using a different date (Appendix A2.5)

Districts weighted by their population size

∗∗∗p < 0.01; ∗∗p < 0.05; p < 0.1